MSA Safety Inc — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that MSA Safety Inc filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.87B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.81B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $1.79B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $1.53B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $1.40B | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | $388.25M | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | $304.39M | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | $314.44M | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | $341.15M | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | $375.25M | Feb 19, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $510.91M | Feb 12, 2026 |
| FY2025 | Sep 30, 2025 | $468.45M | Feb 12, 2026 |
| FY2025 | Jun 30, 2025 | $474.12M | Feb 12, 2026 |
| FY2025 | Mar 31, 2025 | $421.34M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $499.70M | Feb 12, 2026 |
| FY2025 | Sep 30, 2024 | $432.68M | Feb 12, 2026 |
| FY2025 | Jun 30, 2024 | $462.46M | Feb 12, 2026 |
| FY2025 | Mar 31, 2024 | $413.30M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $495.36M | Feb 14, 2025 |
| FY2024 | Sep 30, 2023 | $446.73M | Feb 14, 2025 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $346.14M | Feb 22, 2018 |
| FY2017 | Sep 30, 2017 | $296.13M | Feb 22, 2018 |
| FY2017 | Jun 30, 2017 | $288.78M | Feb 22, 2018 |
| FY2017 | Mar 31, 2017 | $265.77M | Feb 22, 2018 |
| FY2017 | Dec 31, 2016 | $296.03M | Feb 22, 2018 |
| FY2017 | Sep 30, 2016 | $278.23M | Feb 22, 2018 |
| FY2017 | Jun 30, 2016 | $296.00M | Feb 22, 2018 |
| FY2017 | Mar 31, 2016 | $279.27M | Feb 22, 2018 |
| FY2016 | Dec 31, 2015 | $313.32M | Feb 28, 2017 |
| FY2016 | Sep 30, 2015 | $273.75M | Feb 28, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $239.39M | Feb 12, 2026 |
| FY2025 | Sep 30, 2025 | $217.62M | Feb 12, 2026 |
| FY2025 | Jun 30, 2025 | $220.71M | Feb 12, 2026 |
| FY2025 | Mar 31, 2025 | $193.40M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $234.43M | Feb 12, 2026 |
| FY2025 | Sep 30, 2024 | $207.46M | Feb 12, 2026 |
| FY2025 | Jun 30, 2024 | $223.03M | Feb 12, 2026 |
| FY2025 | Mar 31, 2024 | $195.53M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $238.18M | Feb 14, 2025 |
| FY2024 | Sep 30, 2023 | $218.76M | Feb 14, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $86.93M | Feb 12, 2026 |
| FY2025 | Sep 30, 2025 | $69.61M | Feb 12, 2026 |
| FY2025 | Jun 30, 2025 | $62.77M | Feb 12, 2026 |
| FY2025 | Mar 31, 2025 | $59.61M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $87.95M | Feb 12, 2026 |
| FY2025 | Sep 30, 2024 | $66.65M | Feb 12, 2026 |
| FY2025 | Jun 30, 2024 | $72.23M | Feb 12, 2026 |
| FY2025 | Mar 31, 2024 | $58.14M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $76.41M | Feb 14, 2025 |
| FY2024 | Sep 30, 2023 | $65.26M | Feb 14, 2025 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $371.82M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $389.18M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $231.32M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $239.14M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $22.78M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $171.90M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $188.25M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $173.48M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $39.58M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $160.70M | Feb 22, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $65.34M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $66.53M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $67.99M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $57.01M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $57.79M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $58.27M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $57.85M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $52.70M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $50.06M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $46.85M | Feb 22, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $414.25M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $394.71M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $396.65M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $338.87M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $332.86M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $290.33M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $330.50M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $324.78M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $300.06M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $308.24M | Feb 22, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $363.87M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $296.43M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $92.86M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $157.46M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $199.15M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $206.56M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $164.96M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $263.89M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $230.34M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $134.89M | Feb 22, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $68.44M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $54.22M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $42.76M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $42.55M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $43.84M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $48.91M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $36.60M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $33.96M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $23.73M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $25.52M | Feb 22, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.55B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $2.21B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $2.17B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $2.38B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $2.40B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $1.92B | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $1.78B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $1.61B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $1.68B | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $1.35B | Feb 22, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.19B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.06B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $1.20B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $1.45B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $1.56B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $1.07B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $1.01B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $968.49M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $1.08B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $792.71M | Feb 22, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $834.39M | Feb 18, 2022 |
| FY2021 | Dec 31, 2020 | $839.20M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $725.80M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $633.88M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $597.60M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $558.17M | Feb 22, 2018 |
| FY2016 | Dec 31, 2015 | $516.50M | Feb 28, 2017 |
| FY2015 | Dec 31, 2014 | $533.81M | Feb 29, 2016 |
| FY2014 | Dec 31, 2013 | $566.45M | Feb 25, 2015 |
| FY2013 | Dec 31, 2012 | $462.96M | Feb 24, 2014 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $731.59M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $620.90M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $627.53M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $620.62M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $636.86M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $443.27M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $436.68M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $413.64M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $422.19M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $333.28M | Feb 22, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.55B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.35B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $1.14B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $1.16B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $1.05B | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $1.10B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $1.01B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $935.58M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $868.68M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $901.42M | Feb 22, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $165.07M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $164.56M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $146.44M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $162.90M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $140.90M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $160.67M | Feb 16, 2023 |
| FY2021 | Dec 31, 2019 | $152.20M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $140.10M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $134.24M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $113.76M | Feb 22, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $580.93M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $508.01M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $601.69M | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $572.83M | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $597.65M | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | $307.16M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $348.39M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $361.31M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $474.50M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $390.50M | Feb 22, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 12, 2026 |
| FY2025 | Sep 30, 2025 | 1 | Feb 12, 2026 |
| FY2025 | Jun 30, 2025 | 1 | Feb 12, 2026 |
| FY2025 | Mar 31, 2025 | 1 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 12, 2026 |
| FY2025 | Sep 30, 2024 | 1 | Feb 12, 2026 |
| FY2025 | Jun 30, 2024 | 1 | Feb 12, 2026 |
| FY2025 | Mar 31, 2024 | 1 | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | 1 | Feb 14, 2025 |
| FY2024 | Sep 30, 2023 | 1 | Feb 14, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 12, 2026 |
| FY2025 | Sep 30, 2025 | 1 | Feb 12, 2026 |
| FY2025 | Jun 30, 2025 | 1 | Feb 12, 2026 |
| FY2025 | Mar 31, 2025 | 1 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 12, 2026 |
| FY2025 | Sep 30, 2024 | 1 | Feb 12, 2026 |
| FY2025 | Jun 30, 2024 | 1 | Feb 12, 2026 |
| FY2025 | Mar 31, 2024 | 1 | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | 1 | Feb 14, 2025 |
| FY2024 | Sep 30, 2023 | 1 | Feb 14, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 38.91M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 39.26M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | 39.32M | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | 39.21M | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | 39.28M | Feb 16, 2023 |
| FY2021 | Dec 31, 2020 | 39.07M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | 38.84M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | 38.53M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | 38.22M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | 37.74M | Feb 22, 2018 |